✦ LIBER ✦

Effect of keratinocyte growth factor and activin on cell growth in the human prostatic cancer cell line LNCaP

✍ Scribed by Bernhard Planz; Horia Oltean; Thomas Deix; Sandra D. Kirley; Qi Fa Wang; W. S. McDougal; Michael Marberger

Publisher: Springer-Verlag
Year: 2004
Tongue: English
Weight: 207 KB
Volume: 22
Category: Article
ISSN: 0724-4983
DOI: 10.1007/s00345-003-0391-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibitory effects of evodiamine on the

Inhibitory effects of evodiamine on the growth of human prostate cancer cell line LNCaP

✍ Shu-Fen Kan; William J. Huang; Lie-Chwen Lin; Paulus S. Wang 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 563 KB

## Abstract Evodiamine, isolated from a Chinese herbal drug named Wu‐Chu‐Yu, possesses many biological functions. Recently, it has been reported that Wu‐Chu‐Yu exerts an antiproliferative effect on several cancers. Prostate carcinoma initially occurs as an androgen‐dependent tumor and is the second

Growth inhibiting effect of estramustine

Growth inhibiting effect of estramustine on two prostatic carcinoma cell lines, LNCaP and LNCaP-r

✍ Hansenson, M. ;Lundh, B. ;Hartley-Asp, B. ;Pousette, �. 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 443 KB

Effect of tumor necrosis factor-? and in

Effect of tumor necrosis factor-? and interferon-? on the growth of human prostate cancer cell lines

✍ Nakajima, Y. ;DelliPizzi, A. ;Mallouh, C. ;Ferreri, N. R. 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 583 KB

Human recombinant tumor necrosis factor-alpha (rTNF-alpha, 10(-12)-10(-8) M) inhibited the proliferation of androgen-dependent LNCaP cells by 32-56%. In contrast, proliferation of androgen-independent PC-3 and JCA-1 cells was only slightly inhibited, or not inhibited at all, respectively. Human reco

STAT3 mediates IL-6-induced growth inhib

STAT3 mediates IL-6-induced growth inhibition in the human prostate cancer cell line LNCaP

✍ Spiotto, Michael T.; Chung, Theodore D.K. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 486 KB 👁 2 views

## BACKGROUND. In prostate cancer, we and others have observed distinct phenotypic responses to interleukin-6 (IL-6), which acts either as a paracrine growth inhibitor in the LNCaP cell line or as an autocrine growth stimulator in PC-3, DU145, and TSU cell lines. To understand the underlying mechan

Angiogenic factors expressed by human pr

Angiogenic factors expressed by human prostatic cell lines: Effect on endothelial cell growth in vitro

✍ Hepburn, Peter J.; Griffiths, Keith; Harper, Maureen E. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB 👁 2 views

## Background: Antiangiogenic therapy for prostatic cancer should offer additional ways of combating tumor progression. knowledge of the possible angiogenic factors expressed by prostate cancer cell lines would therefore assist in the design and testing of such potential treatments. ## Methods: C

Oct1 regulates cell growth of LNCaP cell

Oct1 regulates cell growth of LNCaP cells and is a prognostic factor for prostate cancer

✍ Daisuke Obinata; Ken-ichi Takayama; Tomohiko Urano; Taro Murata; Jinpei Kumagai; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 522 KB

## Abstract The androgen receptor (AR) plays a critical role in the development and the progression of prostate cancer. Alterations in the expression of AR coregulators lead to AR hypersensitivity, which is one of the mechanisms underlying the progression of prostate cancer into a castrate‐resistan